Select Page

Venus Remedies (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039

Venus Remedies Limited

Company Logo Price: ₹310.25
52 Week Low: ₹281.10
52 Week High: ₹430.00
Market Capital: 396.73 Crore (Smallcap)
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

To predict the Venus Remedies's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Venus Remedies Share Price Target For 2024

The line chart displays the monthly closing prices of Venus Remedies with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Venus Remedies shares in 2024, see the table below.

Venus Remedies Share Price Target Table For 2024

Level Value Analysis
2024 Target 3 324.9 (+4.72%) Price Action: 20 Dec 2024 High
2024 Target 2 321.0 (+3.46%) Price Action: 03 Dec 2024 High
2024 Target 1 317.8 (+2.43%) Price Action: 04 Dec 2024 Low
Current Price 310.25 Venus Remedies's share price as of 23 Dec 2024
Stop Loss 1 306.79 (-1.12%) Price Action: 18 Nov 2024 High
Stop Loss 2 303.64 (-2.14%) Price Action: Oct 2024 Low
Stop Loss 3 300.0 (-3.31%) Price Action: Jul 2023 High

Short-Term Technical Outlook

Current Technical Position: Venus Remedies is displaying bearish momentum trading below key moving averages.

Key Technical Level: The 25-day moving average at ₹316.82 serves as the nearest technical reference point.

Historical Returns: 3-month: -7.22% | 6-month: -12.77% | 1-year: -23.02%

Venus Remedies Share Price Target For 2025

The line chart displays the monthly closing prices of Venus Remedies with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Venus Remedies shares in 2025, see the table below.

Venus Remedies Share Price Target Table For 2025

Level Value Analysis
2025 Target 3 418.77 (+34.97%) Price Action: Chart
2025 Target 2 410.96 (+32.46%) Price Action: Chart
2025 Target 1 406.89 (+31.14%) Fibonacci Extension Level 64.90%
Current Price 310.25 Venus Remedies's share price as of 23 Dec 2024
Stop Loss 1 288.14 (-7.13%) Price Action: 25 Nov 2024 Low
Stop Loss 2 285.2 (-8.08%) Price Action: Nov 2024 Low
Stop Loss 3 281.25 (-9.35%) Price Action: Aug 2005 High

Long-Term Technical Outlook

52-Week Range Analysis: Venus Remedies is currently trading near its 52-week low of ₹281.1, indicating potential value opportunity.

Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.

Long-Term Performance: 1-year: -23.02% | 3-year: +144.63% | 5-year: +144.63%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Venus Remedies Share Price Target Chart and Table From 2024, 2025, 2026 to 2039

Year Target 1 Target 1 YoY Chg % Target 2
Current Price ₹310.25
2024 ₹365.14 +17.69% ₹370.62
2025 ₹330.24 -9.55% ₹422.38
2026 ₹362.66 +9.81% ₹432.55
2027 ₹417.86 +15.22% ₹442.73
2028 ₹452.91 +8.38% ₹459.70
2029 ₹400.49 -11.57% ₹427.42
2030 ₹361.61 -9.7% ₹463.08
2031 ₹396.47 +9.64% ₹473.26
2032 ₹456.10 +15.04% ₹483.43
2033 ₹493.61 +8.22% ₹501.01
2034 ₹435.85 -11.7% ₹465.66
2035 ₹392.98 -9.83% ₹503.78
2036 ₹430.28 +9.49% ₹513.96
2037 ₹494.34 +14.88% ₹524.13
2038 ₹534.31 +8.08% ₹542.32
2039 ₹435.03 -18.58% ₹503.90

Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.

Venus Remedies Brief Company Overview

Venus Remedies Limited: Pharmaceuticals with a Global Reach Venus Remedies Limited, established in 1989, is a leading pharmaceutical company headquartered in India. Venus Remedies is dedicated to developing, manufacturing, and marketing innovative pharmaceutical products that... cater to various therapeutic areas including analgesics, anti-diabetics, antibiotics, and oncology. Broad Product Range: Venus Remedies boasts a comprehensive portfolio of pharmaceuticals, including: Anti-infectives Anticoagulants Anti-diabetic drugs Antibiotics Antifungals Antivirals International Presence: Venus Remedies has a global presence, with its products available in over 70 countries.

Venus Remedies Financial Performance

Metric Value Description
Market Capital 396.73 Crore Market valuation of Venus Remedies's shares.
Revenue (TTM) 561.92 Crore Total revenue generated by Venus Remedies over the past twelve months.
Net Income (TTM) +29.02 Crore Net Profit or Loss after all the expenses over the past twelve months.
Operating Margin +3.83% Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin +5.16% Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+22.7% Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+108.2% Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
8.86 Company's total debt divided by total shareholder equity.
Total Debt 41.74 Crore Sum of Venus Remedies's current & long-term financial obligations.
Total Cash 70.75 Crore Total amount of liquid funds available to Venus Remedies.
Beta 1.07 Beta is greater than 1 indicating that the Venus Remedies's price is more volatile than the market.

Is Venus Remedies A Good Buy For Long Term?

Venus Remedies has experienced an impressive 108.2% increase in earnings and a 22.7% jump in revenue. However, the company's debt remains high at Rs. 41.74 crore. With a profit margin of 5.16%, the company's profitability is moderate. While the stock has generated substantial returns in the past, its recent performance has been volatile. Overall, Venus Remedies appears to be a moderately risky investment with the potential for long-term growth.

Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.

All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.